Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Currents in Pharmacy Teaching & Learning|September 15, 2023
Student-led podcasts to enhance literature evaluation skillsElisabeth M Wang, Tyler J Varisco, J Douglas Thornton, et al.Journal of Pain & Palliative Care Pharmacotherapy|June 1, 2022
Comparing Two Databases to Identify Access to Buprenorphine Treatment for Opioid Use DisorderPrecious Anyanwu, Tyler J Varisco, Matthew A Wanat, et al.Journal of Dual Diagnosis|April 1, 2025
Concurrent Depression Management in Patients with Opioid Use Disorder Undergoing Buprenorphine Therapy: Association with Buprenorphine DiscontinuationVaishnavi Tata, Tyler J Varisco, Dipali V Rinker, et al.Preventive Medicine|November 18, 2024
Comparative effectiveness of high-efficacy and moderate efficacy disease-modifying agents in reducing the annualized relapse rates among multiple sclerosis patients in the United StatesJieni Li, George J Hutton, Tyler J Varisco, et al.BMC Health Services Research|November 1, 2023
Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysisVaishnavi Tata, Randa Al Saadi, Sang Kyu Cho, et al.Journal of the American Pharmacists Association : Japha|July 30, 2026
It's not in stock: Community pharmacists' decision-making and communication when refusing to dispense controlled substance prescriptionsAyobami A Aiyeolemi, Marissa A Johnson, Mattie Sullivan, et al.Clinical Pharmacology and Therapeutics|November 15, 2024
Infection Risk Associated with High-Efficacy Disease-Modifying Agents in Multiple Sclerosis: A Retrospective Cohort StudyJieni Li, George J Hutton, Tyler J Varisco, et al.Frontiers in Oncology|January 26, 2023
Investigation of racial differences in survival from non-small cell lung cancer with immunotherapy use: A Texas studyOlajumoke A Olateju, Zhen Zeng, Oluwasanmi O Adenaiye, et al.Multiple Sclerosis and Related Disorders|September 29, 2024
Factors associated with the initiation of high-efficacy disease-modifying agents over moderate-efficacy disease-modifying agents in multiple sclerosisJieni Li, George J Hutton, Tyler J Varisco, et al.Journal of the American Pharmacists Association : Japha|May 21, 2021
Switching pharmacies leads to gaps in medication possession in individuals treated with buprenorphineTyler J Varisco, Susan Abughosh, Hua Chen, et al.Pageof 4